Business:
Covalent small molecules targeting post-translational modification sites
About:
Covant Therapeutics proclaims expertise in chemistry, proteomics, and deep learning, leveraged in developing covalent therapeutics. Co-founder Ben Ruprecht has over 10 years of expertise in spectrometry-based proteomics and chemoproteomics, acting as head of the Proteomics Platform at Covant.
Senior Associate, Commercial Analytics Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|5 days ago
Clinical Operations Fellowship Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|12 days ago
Senior Associate, Investments Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|12 days ago
Vice President, Head of Clinical Operations (Remot... Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|14 days ago
Entrepreneur-in-Residence, Value-Based Care, Roiva... Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|48 days ago
Associate, Governance Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|100+ days ago
Principal, Roivant Health Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|100+ days ago
Associate, Roivant Health Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|100+ days ago